Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
about
18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETOestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESPositron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PETDifferentiation of aggressive and indolent subtypes of uterine sarcoma using maximum standardized uptake value.¹⁸F-FDG-PET/CT findings of retroperitoneal tumors: a pictorial essay.Advances in imaging techniques for diagnosis of endometrial cancer.Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.Emerging clinical applications of PET based molecular imaging in oncology: the promising future potential for evolving personalized cancer care.Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16α-[18F]fluoro-17β-estradiol.Diagnostic imaging using positron emission tomography for gynecological malignancy.18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma.Case report: MR imaging features of disseminated uterine leiomyosarcoma presenting after hysterectomy with morcellation.
P2860
Q33618400-CA7E4B95-2717-4095-9CE6-7F08D6A86F60Q34029674-A6E5C7C8-0AD2-48F0-B029-8B4C68F57BEFQ34235986-0AAE3430-4815-470D-B2B6-4B2AC867A178Q36326057-F41864E5-616F-4203-9DAC-CF9DA5F2AB51Q37242516-EBF6FAE3-A3FE-42E3-885F-9D63A3D8C4F6Q37273298-F7F77E9E-3988-4138-A6FC-2DF0E5D590F0Q38086122-C8550538-631D-4F23-852C-D1EF1906AF8EQ38089085-B6712B0E-6268-4068-BA49-9B14FBFFFD85Q38205397-8E789D39-FC2E-4B25-A26D-84AA07D86AC2Q38692408-CEE3FA55-397B-4326-9646-4C32BE2BF916Q40527607-8BB53B86-D6DC-4BA0-9310-158034E4AC25Q47669172-42693F50-E6B9-4557-A2A0-3D2F6989C806Q48105266-24C3F108-A2FB-428F-8E0F-4C2FD6DB5A19Q53175645-158B9CF7-E9B6-4944-B612-3BA1E81E078FQ53461192-9BC077CC-7ED8-494C-ABA1-6DA729F4FB41
P2860
Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@en
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@nl
type
label
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@en
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@nl
prefLabel
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@en
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@nl
P2093
P1433
P1476
Uterine tumors: pathophysiolog ...... ucose PET--initial experience.
@en
P2093
Fumikazu Kotsuji
Tetsuji Kurokawa
Tetsuya Mori
Tetsuya Tsujikawa
Yasuhisa Fujibayashi
Yoshio Yoshida
P304
P356
10.1148/RADIOL.2482071379
P407
P577
2008-06-06T00:00:00Z